Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $233.70
- Average 1Y price target
- $282.90+21.05%
- Agreement
- Good
Analysts agreement range is spread less than 15% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall3
- DCF1
- Return on equity5
- Return on assets5
- Debt / equity1
- P/E2
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 2 | $269.00 |
| Last quarter | 10 | $285.40 |
| Last year | 25 | $276.44 |
| All time | 48 | $249.54 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Citigroup | upgrade | Neutral | Buy |
| Oct 7, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Aug 11, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Aug 11, 2026 | UBS | maintain | Neutral | Neutral |
| Aug 11, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Aug 11, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Aug 11, 2026 | Bernstein | maintain | Outperform | Outperform |
| Aug 11, 2026 | Barclays | maintain | Overweight | Overweight |
| Aug 11, 2026 | Baird | maintain | Outperform | Outperform |
| Jul 17, 2026 | Zelman & Assoc | upgrade | Neutral | Outperform |
| Jul 7, 2026 | Goldman Sachs | downgrade | Buy | Neutral |
| May 8, 2026 | Barclays | maintain | Overweight | Overweight |
| May 6, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| May 6, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Apr 8, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Feb 26, 2026 | Truist Securities | maintain | Buy | Buy |
| Feb 25, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Feb 25, 2026 | UBS | maintain | Neutral | Neutral |
| Feb 25, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Feb 25, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Feb 25, 2026 | Barclays | maintain | Overweight | Overweight |
| Jan 15, 2026 | Barclays | maintain | Overweight | Overweight |
| Dec 11, 2025 | Deutsche Bank | maintain | Hold | Hold |
| Dec 10, 2025 | UBS | maintain | Neutral | Neutral |
| Dec 10, 2025 | Barclays | maintain | Overweight | Overweight |
| Dec 10, 2025 | Baird | maintain | Outperform | Outperform |
| Dec 4, 2025 | Wells Fargo | maintain | Overweight | Overweight |
| Dec 2, 2025 | Jefferies | maintain | Buy | Buy |
| Oct 15, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Sep 18, 2025 | Barclays | maintain | Overweight | Overweight |
| Sep 17, 2025 | Wells Fargo | maintain | Overweight | Overweight |
| Sep 17, 2025 | UBS | maintain | Neutral | Neutral |
| Sep 17, 2025 | Truist Securities | maintain | Buy | Buy |
| Sep 17, 2025 | RBC Capital | maintain | Outperform | Outperform |
| Sep 17, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Sep 17, 2025 | Baird | maintain | Outperform | Outperform |
| Sep 4, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Jul 8, 2025 | Wells Fargo | maintain | Overweight | Overweight |
| Jun 9, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Jun 6, 2025 | JP Morgan | maintain | Overweight | Overweight |